Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
01/2007
01/17/2007CN1895268A Externally-applied medicine with burn, ambustion and insult treatment and its preparation
01/17/2007CN1895267A Composite gel of CMC and collagen synthase inhibitor for preventing adhered Fe crosslinked and its preparation
01/17/2007CN1895266A Compound slow-releasing immune enhancer for cock
01/17/2007CN1895265A Active medicinal matter for improving adrenal cortex hormone function prepared by coarse solomon's seal polysaccharide
01/17/2007CN1895264A Medicinal use of quercetin-3-0-beta-D-glucancoside
01/17/2007CN1895263A Use of taurine in preparation of injection containing puerarin
01/17/2007CN1895262A Emulsion for injecting epirubicin and its production
01/17/2007CN1895261A Use of pokeroot saponin A in preparation medicine for treating rheumatoid arthritis
01/17/2007CN1895260A Sucrose-ferri aseptic powdery injection and its preparation
01/17/2007CN1895259A Preparation of injection for treating cardiovascular disease
01/17/2007CN1895258A Diflunisal slow-releasing preparation and its making method
01/17/2007CN1895257A Use of 20(S)-protopanoxadiol in preparation of anti-bowelcancer medicine
01/17/2007CN1895256A Use of 20(S)-protopanoxadiol in preparation of antidepressant medicine
01/17/2007CN1895255A Archaeus-agent capsules and production thereof
01/17/2007CN1895254A Gynopathic effervescent tablets and production thereof
01/17/2007CN1895253A Lomesaline hydrochloride eye drops and preparation thereof
01/17/2007CN1895252A Zirasitone mesylate soluble medicinal preparation
01/17/2007CN1895251A Stabilized nalmefene hydrochloride injection and its preparation
01/17/2007CN1895250A Gliquilone slow-releasing preparation
01/17/2007CN1895249A Compound preparation for treating hypentension
01/17/2007CN1895248A Prescription of herba fibraureae recisae preparation
01/17/2007CN1895247A Buccale tablet preparation and its making method
01/17/2007CN1895246A Medicine for treating colpitis and cervical erosio
01/17/2007CN1895245A Medicinal mixture for treating arrhythmia
01/17/2007CN1895244A Medicinal composition for preventing and treating cancer diseases
01/17/2007CN1895243A Danshen-root ketone IIA oral-cavity disintegrating tablets
01/17/2007CN1895242A Diclofenac salt pleximetric paste and its production
01/17/2007CN1895241A Composition of long-acting oral pills of Yansuan Tanshuluoxin and its production
01/17/2007CN1895240A Medicine-releasing system of compound amithiourea preparation
01/17/2007CN1895239A Curcumin preparation and its making method
01/17/2007CN1895238A Protection of dithiothreitol for crystal protein and use thereof
01/17/2007CN1895237A Officinal magnolia phenol lipid frozen dried powder preparation and its use in preparing drug for cancers
01/17/2007CN1895236A Oral-cavity adhering sheets and production thereof
01/17/2007CN1895233A Medicament formulation with a controlled release of an active agent
01/17/2007CN1895232A Chlorsaten drop balls and production thereof
01/17/2007CN1895231A Chlorpirgray drop balls and production thereof
01/17/2007CN1895230A Lisinopril drop balls and production thereof
01/17/2007CN1895229A Monopril drop balls and production thereof
01/17/2007CN1895228A Erbsaten drop balls and production thereof
01/17/2007CN1895227A Benapryzine drop ball and its production
01/17/2007CN1895226A Matrine elaioplast drop ball and its preparation
01/17/2007CN1895225A Brilliant mycomycin elaioplast preparation and its making method
01/17/2007CN1895224A Polyvinyl-phosphorylcholine elaioplast preparation and its making method
01/17/2007CN1895221A Fast-effective oral analgesic
01/17/2007CN1895220A 20(R)-ginseng sapoglycoside Rg3 medicinal soluble intermediate and its production
01/17/2007CN1895219A Bendalysine eye gel preparation and its making method
01/17/2007CN1895218A Pyrrolechrisxi and its sodium-salt eye-gel preparation and its making method
01/17/2007CN1295331C Oncogene, recombinant protein derived therefrom, and uses thereof
01/17/2007CN1295251C Glycosaminoglycans derived from K5 polysaccharide having high antithrombin activity and process for their preparation
01/17/2007CN1295242C 3'-prodrugs of 2'-deoxy-beta-L-nucleosides
01/17/2007CN1295229C Crystals of taxane derivative and process for their production
01/17/2007CN1295227C Barbituric acid derivs with antimetastatic and antitumor activity
01/17/2007CN1295225C Bibenzyl compound plagiochin E and its extraction separation method and application
01/17/2007CN1295221C Substituted heterocyclic compounds
01/17/2007CN1295216C Molindone derivatives and use for preparing antineoplastic medicine thereof
01/17/2007CN1295215C New Optical active derivative of flavo acidamide, its preparation method and its medicinal composition and use
01/17/2007CN1295213C Fluorinated cycloalkyl-derivatized benzoylguanidines and their uses as medicament
01/17/2007CN1294983C Medicine for treating facial paralysis and its preparing method
01/17/2007CN1294978C Composition for dispelling spot and its preparation method
01/17/2007CN1294974C Plaster for treating rheumatoid, fracture, sprain and arthritis and preparation method thereof
01/17/2007CN1294956C Oral compositions for the treatment of scalp disorders
01/17/2007CN1294938C Skin inflammation eliminating tincture
01/17/2007CN1294937C Chinese medicine preparation for treating bromhidrosis
01/17/2007CN1294928C Traditional Chinese medicine pills for treating toothache, and its prepn. method
01/17/2007CN1294923C Use of ammopiptanthus ester in preparation of anti- liver cancer medicine
01/17/2007CN1294915C Eliminating stasis and tissue generation toxic removing pill
01/17/2007CN1294914C Chinese medicinal injection liquid for giving up drug
01/17/2007CN1294913C Medication combination of containing finasteride and cyclodextrin or ramification
01/17/2007CN1294912C Itraconazole hydrochloride composition and freeze-dried powder injection thereof
01/17/2007CN1294911C Tetrandrine preparation for eyes
01/17/2007CN1294910C Medicinal composition having antiseptic and anti-inflammatory function
01/17/2007CN1294909C Novel anti-biological cell free-radical oxidation injury mixture
01/17/2007CN1294908C Oral gliclazide sustained release formulation
01/17/2007CN1294907C 盐酸氨溴索颗粒剂 Ambroxol Hydrochloride Granules
01/17/2007CN1294906C Method for improving quality of meat by supplementing pig diets and concentrates used therefor
01/17/2007CN1294905C Drug composition for treating osteoporosis
01/17/2007CN1294899C Black soya bean oil contained compound gelling agent
01/17/2007CN1294896C Agents for inhibiting or restoring skin damage caused by drying and method of evaluating the same
01/16/2007US7164035 the complex increase the activity of antioxidant enzymes catalase and glutathione peroxidase, and the antioxidant protein metallothionein by protect retinal pigment epithelial cells from increasing hydrogen peroxide concentrations
01/16/2007US7164034 treating a disorder selected from obsessive compulsive disorder (OCD), agoraphobia, agoraphobia without history of panic disorder, specific phobia, social phobia, post traumatic stress syndrome (PTSD), restless legs syndrome, premenstrual dysphoric disorder, hot flashes, and fibromyalgia
01/16/2007US7164030 Process
01/16/2007US7164029 Process for the preparation of benzylimidazole derivatives
01/16/2007US7164027 Aralkyl ester soft drugs
01/16/2007US7164024 Muscarinic acetylcholine receptor antagonist; Parkinson's disease; dystonia; analgesics; irritable bowel syndrome
01/16/2007US7164017 Exhibit electrophysiological activity
01/16/2007US7163961 useful in preventing or treating diseases accompanied by a decrease in bone weight and hypertension or diseases resulting from hypertension
01/16/2007US7163960 Treatment and prevention of inflammatory disorders
01/16/2007US7163959 Prostagladin derivatives for the treatment of glaucoma or ocular hypertension
01/16/2007US7163958 Compositions comprising nitrosated NSAID and compound that donates, transfers or releases nitric oxide, or stimulates endogenous synthesis of nitric oxide; treatment of inflammation, pain, fever, gastrointestinal disorders
01/16/2007US7163957 anti-psychotic; selectively interact with the dopaminergic receptors of the D2/D3 subtypes and the serotoninergic receptors of the 5-HT1A subtype at the level of which they behave as antagonists and agonists, respectively
01/16/2007US7163956 Substituted fullerene compositions and their use as antioxidants
01/16/2007US7163955 useful in treating members of the Flaviviridae family of viruses
01/16/2007US7163954 Substituted naphthyl benzothiophene acids
01/16/2007US7163953 Benzylether derivatives
01/16/2007US7163952 Azole compound and medicinal use thereof
01/16/2007US7163951 N-biarylmethyl aminocycloalkanecarboxamide derivatives
01/16/2007US7163950 Surfactants as malarial chloroguine resistance reversal agents
01/16/2007US7163949 for the treatment of various neurological and psychological disorders; compounds which block reuptake of norephinephrine, dopamine, and serotonin with particular selectivity ratios; reduced side effect profile
01/16/2007US7163948 interact with regions of DNA that can form quadruplexes and act as tumor suppression genes with high affinity; can reduce expression of highly proliferate genes and are utilized for treating cancers
01/16/2007US7163947 1-Amino 1H-imidazoquinolines